ASPE Conversion Disclosure
Arch Venture Fund X, L.p. · SEC Form 4 · Filed Nov 2, 2026
Conversion
Reported value range
Not reported
Arch Venture Fund X, L.p. 10% owner
ASPE
Transaction date
Nov 2, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed same day
ASPE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A-2 Convertible Preferred Stock on Common Stock
- Quantity / price
- 286,304 shares
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001193125-26-444147
Filing cohort
Transactions in this filing
Showing 15 of 21
Trades
21
Issuers
1
Estimated value
$20M
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Buy | Nov 2, 2026 | $1M |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Buy | Nov 2, 2026 | $999.99K |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE Current | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Buy | Nov 2, 2026 | $18M |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |
| Aspen Neuroscience, Inc. ASPE | Conversion | Nov 2, 2026 | Not reported |